LEMAITRE VASCULAR INC 8-K

What Happened

LeMaitre Vascular, Inc. (LMAT) announced preliminary financial and operational results for the quarter ended March 31, 2026 by filing an 8‑K on May 5, 2026 (Item 2.02). The company furnished a press release with those results as Exhibit 99.1 to the filing. The report was signed by Chief Financial Officer Dorian LeBlanc.

Key Details

• Filing date: May 5, 2026 (Form 8‑K, Item 2.02: Results of Operations and Financial Condition).
• Reporting period: quarter ended March 31, 2026 (preliminary results announced).
• Exhibit furnished: press release issued May 5, 2026 (Exhibit 99.1).
• Signature: 8‑K signed by CFO Dorian LeBlanc; interactive XBRL cover page also included (Exhibit 104).

Why It Matters

Preliminary quarterly results give investors an early look at the company’s earnings, revenue and operational trends for the period and can affect short‑term market reaction. This 8‑K furnishes the press release but does not replace the forthcoming quarterly filings (e.g., Form 10‑Q) that will provide full financial statements and disclosures. Investors should read the press release (Exhibit 99.1) and monitor the company’s subsequent filings for audited and detailed figures.